Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group

G. J. Cuchural, F. P. Tally, N. V. Jacobus, T. Cleary, S. M. Finegold, G. Hill, P. Iannini, J. P. O'Keefe, C. Pierson

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

A nationwide susceptibility survey of 557 isolates of the Bacteroides fragilis group was continued in 1986. The most active β-lactam drugs were imipenem and ticarcillin-clavulanic acid, which had 0.2 and 1.7% resistance, respectively. The rank order of activity of β-lactam drugs was imipenem, tricarcillin-clavulanic acid, cefoxitin, piperacillin, moxalactam, ceftizoxime, cefotetan, cefotaxime, cefoperazone, and ceftazadime.

Original languageEnglish (US)
Pages (from-to)479-480
Number of pages2
JournalAntimicrobial agents and chemotherapy
Volume34
Issue number3
DOIs
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group'. Together they form a unique fingerprint.

  • Cite this

    Cuchural, G. J., Tally, F. P., Jacobus, N. V., Cleary, T., Finegold, S. M., Hill, G., Iannini, P., O'Keefe, J. P., & Pierson, C. (1990). Comparative activities of newer β-lactam agents against members of the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 34(3), 479-480. https://doi.org/10.1128/AAC.34.3.479